Please do not adjust margins
Organic & Biomolecular Chemistry
Page 5 of 7
DOI: 10.1039/C7OB02552A
Journal Name
COMMUNICATION
K2A-pDNA complexes in both cell lines studied. When the HaCaT cells were treated with the fluorescein-labeled
complexes were prepared by overnight incubation, the dendrimers, K2A-cf and K2C-cf, following which, the cells were
transfection efficiency was even higher than that of imaged to show the intracellular localization of the
LipofectamineTM 2000. Given the fact that the transfection dendrimers. As seen in Figure S3 (ESI), K2C-cf was taken up to
efficiency of LipofectamineTM 2000 in vivo is limited by its high a larger extent than K2A-cf. Further, the fluorescence appears
associated cytotoxicity, this study illustrates the potential of to be distributed in the cytoplasm as well as in the nucleus and
the K2C dendrimer as a molecular transporter that can be used nucleoli, illustrating their cell penetration efficiency.
at a lower concentration, with minimal cytotoxic effects.
Conclusions
In summary, we have designed and synthesized efficient
lysine-based generation-2 dendrimers bearing amide- or
carbamate-linkages at the branch points. The dendrimers
possess good cell-penetration properties, and are capable of
delivering cargo molecules such as pDNA into cells at an
Figure 6. Transfection of CHO-K1 cells by pMIR-Report luciferase complexes with K2A
efficiency that is comparable or even better than the standard
and K2C dendrimers. (A) Dendrimer-pDNA complexes were prepared by incubation for
transfection agent, Lipofectamine, when their complexes with
1 h. (B) Comparison of transfection when K2C-pDNA complexes were prepared by
pDNA were prepared by incubation overnight. Taken together
incubation for 1 h or overnight.
with their lower cytotoxicity, this makes them worthy
candidates for further development as molecular transporters.
Conflicts of interest
There are no conflicts to declare.
Figure 7. Transfection of HaCaT cells by pMIR-Report luciferase complexes with K2A
Notes and references
and K2C dendrimers. (R-X-R)4/Dendrimer-pDNA complexes were prepared by
‡ MG and MF gratefully acknowledge research funding (BSC0302) from CSIR, New
Delhi. AKY thanks CSIR, New Delhi, for a research fellowship.
incubation (A) for 1 h or (B) overnight.
The cytotoxicity of the K2A and K2C dendrimers alone and in
the form of complexes with pDNA was assessed by the
standard MTT cell viability assay (Figures 8 and S2 (ESI)). While
K2A by itself showed a slight toxic effect in CHO-K1 cells
(Figure 8C), the cytotoxicity of the dendrimer-pDNA complexes
was minimal even after 24h. This data is consistent with that
obtained for the (R-X-R)4-amide and -carbamate oligomers,2b
making K2A and K2C advantageous over commercial
transfection agents such as Lipofectamine, which displayed
considerable cytotoxicity in comparison.2b
1
2
N. Tamilarasu, H. Ikramul, M. R. Tariq, J. Am. Chem.
Soc.,1999, 121, 1597-1598.
(a) P. Wender, J. Rothbard, T. Jessop, E. Kreider, B. Wylie, J.
Am. Chem. Soc., 2002, 124, 13382-13383. (b) K. M. Patil, R. J.
Naik, Rajpal, M. Fernandes, M. Ganguli, V. A. Kumar, J. Am.
Chem. Soc., 2012, 134, 7196−7199.
3
4
(a) P. Wender, D. Mitchell, K. Pattabiraman, E. Pelkey, L.
Steinman, J. Rothbard, Proc. Natl. Acad. Sci., USA, 2000, 97
13003-13008. (b) W. Huang, J. Seo, J. Lin, A. Barron, Mol.
BioSyst., 2012, , 2626-2628. (c) T. Schröder, K. Schmitz, N.
,
8
Niemeier, T. Balaban, H. Krug, U. Schepers, S. Bräse,
Bioconjugate Chem., 2007, 18, 342-354.
(a) Y. Kim, S. Binauld, and M. H. Stenzel, Biomacromolecules,
2012, 13, 3418−3426 (b) G. Gasparini, E. K. Bang, G.
Molinard, D. V. Tulumello, S. Ward, S. O. Kelley, A. Roux, N.
Sakai, S. Matile, J. Am. Chem. Soc., 2014, 136, 6069−6074. (c)
N. J. Treat, D. Smith, C. Teng, J. D. Flores, B. A. Abel, A. W.
York, F. Huang, C. L. McCormick, ACS Macro Lett., 2012, 1,
100−104.
5
6
(a) S. Abes, H. Moulton, P. Clair, P. Prevot, D. Youngblood, R.
Wu, P. Iversen, B. Lebleu, J. Controlled Release, 2006, 116
,
304-313. (b) P. A. Wender, M. A. Huttner, D. Staveness, J. R.
Vargas, A. F. Xu, Mol. Pharmaceutics, 2015, 12, 742−750.
(a) J. B. Rothbard, E .Kreider, C. L. VanDeusen, L. Wright , B.
L. Wylie, P. A. Wender, J. Med. Chem., 2002, 45, 3612-3618.
(b) Y. Demizu, M. Oba, K. Okitsu, H. Yamashita, T. Misawa, M.
Tanaka, M. Kurihara, S. H. Gellman, Org. Biomol. Chem.,
2015, 13, 5617–5620. (c) N. E. Zhou, B. -Y. Zhu, B. D. Sykes, R.
S. Hodges, J. Am. Chem. Soc., 1992, 114, 4320-4326.
Figure 8. Effect of dendrimers (left panels) and dendrimer-pDNA complexes (right
panels) on cell viability after 4 h in CHO-K1 (A and B respectively) and HaCaT cells (C
and D respectively).
7
(a) A. F. Saleh, A. Arzumanov, R. Abes, D. Owen, B. Lebleu,
M.J. Gait, Bioconjugate Chem. 2010, 21, 1902–1911. (b) A.
Eggimann, E. Blattes, S. Buschor, R. Biswas, S. M. Kammer, T.
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 5
Please do not adjust margins